Brind.

Former Ralph Lauren Executive Appointed to Biotech Board

1 report, 1 independent Updated Wed 00:00
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Tempest Therapeutics announced the appointment of Nancy Freda-Smith to its board of directors, where she will serve as Chair of the Audit Committee. Ms. Freda-Smith brings experience from her tenure as Chief Audit and Risk Officer at Ralph Lauren, where she managed internal audit and Sarbanes-Oxley Act compliance.

From manilatimes.net

Why it matters

Some supportBrind's analysis of the reports

The appointment connects high-level corporate governance experience from a major brand to a clinical-stage biotechnology company. Her background includes leading financial and governance frameworks for global organizations.

From manilatimes.net

Who's involved

  • Ralph LaurenFormer company where Nancy Freda-Smith served as Chief Audit and Risk Officer

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped